XML 23 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating Activities    
Net loss $ (20,042) $ (730,096)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depletion, depreciation and accretion 98,300 131,118
Goodwill impairment (Note 5) 0 102,581
Asset impairment (Note 5) 0 507,093
Deferred tax expense (recovery) 26,809 (62,796)
Stock-based compensation expense (recovery) (Note 7) 6,597 (707)
Amortization of debt issuance costs (Note 6) 2,682 2,774
Unrealized foreign exchange loss 16,945 22,335
Derivative instruments loss (gain) (Note 12) 47,540 (9,417)
Cash settlements on derivatives instruments (45,041) 9,970
Other financial instruments (gain) loss (Note 12) (12,425) 61,286
Other non-cash loss 0 2,026
Cash settlement of asset retirement obligation (483) (199)
Non-cash lease expenses 1,222 1,494
Lease payments (1,239) (1,404)
Net change in assets and liabilities from operating activities (Note 13) 17,956 23,288
Net cash provided by operating activities 138,821 59,346
Investing Activities    
Additions to property, plant and equipment (109,650) (56,378)
Proceeds on disposition of investment, net of transaction costs (Note 12) 14,632 0
Changes in non-cash investing working capital (Note 13) 709 (69,549)
Net cash used in investing activities (94,309) (125,927)
Financing Activities    
Proceeds from debt, net of issuance costs (Note 6) (125) 88,382
Repayment of debt (Note 6) (40,000) (7,000)
Proceeds from exercise of stock options 19 0
Lease payments (1,269) (307)
Net cash (used in) provided by financing activities (41,375) 81,075
Foreign exchange loss on cash, cash equivalents and restricted cash and cash equivalents (528) (754)
Net increase in cash, cash equivalents and restricted cash and cash equivalents 2,609 13,740
Cash, cash equivalents and restricted cash and cash equivalents, beginning of period (Note 13) 17,523 11,075
Cash, cash equivalents and restricted cash and cash equivalents, end of period (Note 13) $ 20,132 $ 24,815